Research Paper Volume 13, Issue 12 pp 16541—16566

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment


Figure 7. Pan-cancer analysis of FGFR3 alterations and distribution. (A) The alteration (mutation and CNVs) frequency of FGFR3 across various tumor types. (B) The distribution of CNV cases along with mutations located in protein functional domains.